Latest Prescription Drugs news
Americans Struggling With High Cost of Prescription Drugs
posted September 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Adjuvant Pembrolizumab Cuts Recurrence in Stage II Melanoma
posted September 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Pfizer Recalls All Lots of Chantix Due to Potential Carcinogen
posted September 17th
by modernClinician Editorial Team
by modernClinician Editorial Team
Most With AD, MCI Would Have Been Excluded From Aducanumab Clinical Trials
posted September 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus Monthly Specialist Briefings
Stay Connected
